FindTrial
Sign In

Correlation between CYP2C19 polymorphism and clopidogrel efficacy in patients with brain infarction in southern Jiangxi province

Correlation between CYP2C19 polymorphism and clopidogrel efficacy in patients with brain infarction in southern Jiangxi province

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17014126
Enrollment
Unknown
Registered
2017-12-24
Start date
2017-12-31
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

ACI:Nil

Sponsors

The First Affiliated Hospital of Gannan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Chinese patients with acute cerebral infarction

Exclusion criteria

Exclusion criteria: exposure to thienopyridine or GP IIb/IIIa inhibitor within one week; cerebral embolism; intracranial hemorrhage after cerebral infarction

Design outcomes

Primary

MeasureTime frame
platelet aggregation;genotype;—

Countries

China

Contacts

Public ContactZhimai Lyu

The First Affiliated Hospital of Gannan Medical University

dummy002233@126.com+86 15970070582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026